Evidence map›Paper›PMID 9436978›Full record

ArticleGenes & development1998

HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection.

M A Vodicka, D M Koepp, P A Silver, M Emerman

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 1 synthesis or guideline pooled it, 332 citations in OpenAlex.

  1. HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.Microbiology and molecular biology reviews : MMBR · 2016
    Pooled it
  2. HIV-1 Vif and Vpr cooperatively modulate the cell cycle to maximize per-cell virion production.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Contribution of yeast models to virus research.Applied microbiology and biotechnology · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. HIV-1 Vpr counteracts HLTF-mediated restriction of HIV-1 infection in T cells.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  19. Article
  20. The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.International journal of molecular sciences · 2017
    Review

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

M A VodickaDivisions of Molecular Medicine and Basic Science, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 USA.
D M Koepp
P A Silver
M Emerman
Dana-Farber Cancer Institute · USFred Hutch Cancer Center · US

Funding

TARGETING RETROVIRAL VECTORS TO HEMATOPOIETIC STEM CELLSP01HL053762 · NHLBI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI KAN, YUET W · 1994 to 2004
$5.1M
TRANSPORT OF PROTEINS IN AND OUT OF THE NUCLEUSR01GM036373 · NIGMS · PRINCETON UNIVERSITY · PI SILVER, PAMELA A · 1986 to 2016
$2.5M
NHLBI NIH HHS P01 HL053762NHLBI NIH HHS P01HL53762NIGMS NIH HHS R01 GM036373NIGMS NIH HHS R01GM36373
6 · The paper itself

Abstract

HIV-1 Vpr promotes nuclear entry of viral nucleic acids in nondividing macrophages and also causes a G2 cell-cycle arrest. Consistent with its role in nuclear transport, we show Vpr localizes to the nuclear envelope in both human and yeast cells. Like the importin-beta subunit of the nuclear import receptor, Vpr also interacts with the yeast importin-alpha subunit and nucleoporins. Moreover, overexpression of either Vpr or importin-beta in yeast blocks nuclear transport of mRNAs. A mutant form of Vpr (Vpr F34I) that does not localize at the nuclear envelope, or bind to importin-alpha and nucleoporins, renders HIV-1 incapable of infecting macrophages efficiently. Vpr F34I, however, still causes a G2 arrest, demonstrating that the dual functions of Vpr are genetically separable. Our data suggest Vpr functionally resembles importin-beta in nuclear import of the HIV-1 pre-integration complex and this function is essential for the role of Vpr in macrophage infection, but not G2 arrest.

Indexed as

alpha Karyopherinsbeta KaryopherinsCell NucleusCells, CulturedFluorescent Antibody Technique, IndirectG2 PhaseGene Products, vprHeLa CellsHIV-1HumansMacrophagesNuclear EnvelopeNuclear ProteinsPoint MutationRNA, MessengerT-Lymphocytesalpha Karyopherinsbeta KaryopherinsGene Products, vprNuclear ProteinsRNA, Messengervpr Gene Products, Human Immunodeficiency Virus

Identifiers

PMID9436978
PMCPMC316441
OpenAlexW2146847077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.